Inventor

WAGNON JEAN

FR33 patents

⚠️ This page may combine multiple inventors who share the name “WAGNON JEAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

WAGNON JEAN

SANOFI SA

1-benzenesulfonyl-1-1,3-dihydroindol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present

1-benzenesulfonyl-1,3-dihydro-indol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present

1-benzenesulfonyl-1,3-dihydroindol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present

1-benzenesulfonyl-1,3-dihydro-indol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present

1-benzenesulfonyl-1,3-dihydro-indol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present

N-sulfonylindoline derivatives, their preparation and the pharmaceutical compositions in which they are present

1,3-dihydroindol-2-one derivatives substituted in the 3-position by a nitrogen-containing group, their preparation and the pharmaceutical compositions in which they are present

N-sulfonylindoline derivatives, their preparation and the pharmaceutical compositions in which they are present

N-sulfonylindoline derivatives, their preparation and the pharmaceutical compositions in which they are present

Process for the stereospecific synthesis of indole derivatives

Indol-2-one derivatives

Indole derivatives of tryptamine and cardiovascular compositions thereof

Peptide amino-alcohol derivatives containing a tetrasubstituted carbon atom, inhibiting renin and acid proteases, process for obtention and therapeutical use

Peptide derivatives which inhibit renin and acid proteases

Peptide derivatives, analogous to pepstatin, which inhibit renin and acid proteases

4[3-(1,1-Dimethyl-2-3(3-indolyl)ethylamino)-2-hydroxypropoxy]indole

Ethers of phenol active on the cardiovascular system, process for preparing same and use thereof in drugs

SANOFI AVENTIS

Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use

Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof

(4-phenylpiperazin-1-yl)acylpiperidine derivatives, preparation thereof and application of same in therapeutics

4-[(arylmethyl)aminomethyl]piperidine derivatives, their preparation and their therapeutic application

Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof

1,3-dihydro-2H-indol-2one derivatives, process for preparing them and pharmaceutical compositions containing them

Acyloxypyrrolidine derivatives, preparation thereof and application thereof in therapeutic

Indolizine derivatives, method for preparing same, and therapeutic compositions comprising same

1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them

1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them

SANOFI SYNTHELABO

1,3-dihydro-2H-indol-2-one derivatives, method for preparing same and pharmaceutical compositions containing them

1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for V1b and V1a arginine-vasopressin receptors

1,3-dihydro-2H-indol-2-one derivatives, preparation method and pharmaceutical composition containing them

1,3-dihydro-2h-indol-2-one, preparation method and pharmaceutical compositions containing same

SANOFI ELF

N-sulfonylindoline derivatives, their preparation and the pharmaceutical compositions in which they are present

CLIN MIDY

3-Indolyl alkylene amino propanols and cardiovascular compositions thereof